Investors

Growing Shareholder Value

About Abiomed

Abiomed (NASDAQ: ABMD) is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. CEO, Chairman, and President Michael R. Minogue has focused the company’s efforts on developing ground-breaking technologies designed to improve the patient outcomes focused on native heart recovery. Founded in 1981 for the purpose of developing the world’s first artificial heart, Abiomed has remained dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.

2017 Annual Report Press Releases
PRICE $174.62
CHANGE (%) 2.41 (1.40%)
VOLUME 209,566
NASDAQ (US DOLLAR)
Data as of Oct 20, 2017 4:00 PM ET
Delayed at least 20 minutes.